Cyp2d6-guided Dosing
CYP2D6-Guided Dosing is a personalized dosing strategy that uses genetic and enzymatic activity data of the CYP2D6 enzyme to tailor drug regimens according to an individual’s metabolic phenotype, thereby optimizing therapeutic efficacy and minimizing adverse effects.
87
Publications
5K
Citations
658
Authors
271
Institutions
Publications per year
2017–2026
23
Parents
87
JK Hicks, Katrin Sangkuhl, JJ Swen et al. · Clinical Pharmacology & Therapeutics · 2016 · 678 citations · Full text
J. Kevin Hicks, Jesse J. Swen, Caroline F. Thorn et al. · Clinical Pharmacology & Therapeutics · 2013 · 453 citations · Full text
Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger et al. · Clinical Pharmacology & Therapeutics · 2011 · 368 citations · Full text
1–5 of 87
658
Indiana University – Purdue University Indianapolis, United States
6 publications · 1.1K citations
6
h-index
5
h-index
5
h-index
5
h-index
4
h-index
1–5 of 658
271
Indiana University – Purdue University Indianapolis
Indianapolis, United States
9 h-index
27 publications
3.7K citations

Leiden University Medical Center
Leiden, The Netherlands
7 h-index
39 publications
3.3K citations
Indiana University School of Medicine
Indianapolis, United States
5 h-index
18 publications
2.6K citations
University of Michigan
Ann Arbor, United States
5 h-index
7 publications
1.5K citations
Erasmus MC
Rotterdam, The Netherlands
5 h-index
27 publications
1.4K citations
University of Washington
Seattle, United States
4 h-index
13 publications
727 citations

Children's Mercy Hospital
Kansas City, United States
4 h-index
4 publications
1.5K citations

Karolinska Institutet
Stockholm, Sweden
4 h-index
15 publications
581 citations
1–8 of 271
11 publications · 505 citations
11
h-index
10 publications · 379 citations
10
h-index
4 publications · 355 citations
4
h-index
CPT · 4 publications · 1.6K citations
4
h-index
3 publications · 90 citations
3
h-index
1–5